MicroRNAs are small non-coding RNAs that regulate cellular development by interfering with mRNA stability and translation. We defined the kinetics of global microRNA expression during the differentiation of murine hematopoietic progenitors into megakaryocytes. Of 435 miRNAs analyzed, 13 were upregulated and 81 were downregulated. Many of these changes are consistent with miRNA profiling studies of human megakaryocytes and platelets, although new patterns also emerged. Among 7 conserved miRNAs that were upregulated most strongly in murine megakaryocytes, 6 were also induced in the related erythroid lineage. MiR-146a was strongly upregulated during mouse and human megakaryopoiesis, but not erythropoiesis.
Introduction
MicroRNAs (miRNAs) are small, non-coding RNAs that inhibit protein expression post transcriptionally by binding specific target mRNAs via Watson-Crick base pairing to repress translation or induce nucleolytic cleavage (reviewed in [1] [2] [3] [4] [5] ). MiRNAs are frequently conserved in evolution and play diverse roles in the development and function of many tissues, including hematopoietic. Deregulation of miRNA expression is involved in numerous human diseases, including leukemias and other hematopoietic disorders [6] [7] [8] [9] .
Over 500 human miRNAs have been identified and roughly 1000 are estimated to exist.
Numerous studies have examined the dynamics of miRNA expression during normal hematopoiesis and identified individual miRNAs that promote the development and/or function of specific lineages. For example, activation of miR-451 10, 11 and repression of miR-15a 12 are required for erythropoiesis. MiR-223 regulates granulocyte proliferation and function 13 and miR-155 regulates activities of the T-cell receptor 14 . MiRNAs are also expressed in megakaryocytes and platelets where they are likely to regulate lineage development and function. Garzon et al showed that differentiation of human CD34 + cells into megakaryocytes is accompanied by downregulation of numerous miRNAs, likely enhancing protein expression from target mRNAs that encode key megakaryocytic transcription factors 15 . MiR-155 is downregulated during megakaryocytic differentiation and targets mRNAs encoding transcription factors Ets-1 and Meis1, which activate megakaryocyte genes 16 . Other miRNAs appear to positively regulate megakaryopoiesis and platelet formation. For example, thrombopoietin induces miR-150, which in turn directs megakaryocyte-erythroid progenitors (MEPs) toward megakaryocytic differentiation, at least in part by repressing expression of transcription factor cFor personal use only. on April 2, 2017 . by guest www.bloodjournal.org From myb 17, 18 . Mir-34a is reported to enhance megakaryocytic differentiation by repressing several target mRNAs including c-myb and G1 phase cyclin dependent kinases 19 . In 5q-syndrome, haploinsufficiency of miR-146a and miR-145 stimulates megakaryopoiesis indirectly by activating innate immunity 9 . Specifically, these miRNAs target mRNAs encoding Tollinterleukin-1 receptor-domain-containing adaptor protein (TIRAP) and tumor necrosis factor receptor-associated factor-6 (TRAF6), which activate Toll-like receptor (TLR) signaling via nuclear factor κΒ 20,21 . This pathway is activated upon reduced dosage of miR-146a and miR-145, thereby stimulating the production of megakaryopoietic cytokines, such as IL-6.
Additionally, numerous miRNAs and their associated regulatory proteins including Dicer and Argonaut 2 are expressed abundantly in platelets, which lack nuclei but contain mRNAs undergoing translation 22 . Thus, miRNAs are likely to regulate mature platelet functions both positively and negatively by modulating protein synthesis therein.
These previous studies begin to define how miRNAs regulate platelet production and function.
Further investigation in this area should provide new insights into the basic biology of hematopoiesis and pathologic conditions associated with excess bleeding or thrombosis. We sought to define the kinetics of global miRNA expression during the differentiation of murine fetal liver hematopoietic progenitors into megakaryocytes. We utilized this approach for several reasons. First, earlier studies analyzing miRNA expression during normal megakaryopoiesis mainly examined human progenitors 15, 17, 22 . We investigated this process in mice since interspecies comparison could provide useful information on the evolution of miRNA functions.
Moreover, changes in megakaryocyte miRNA expression that are conserved between species may reflect biological significance. Murine systems represent an excellent model to study
For personal use only. on April 2, 2017 . by guest www.bloodjournal.org From megakaryopoiesis since progenitors are amenable to genetic manipulation both in vivo and in vitro and relatively pure cultures of murine megakaryocytes can be generated from fetal liver rapidly, within 3-5 days. We used microarrays to interrogate the expression kinetics of 435 miRNAs during murine megakaryopoiesis. Our results generally agree with prior human studies and identify new miRNAs that are differentially regulated. In addition, we show that miR-146a is strongly upregulated during megakaryopoiesis, contrary to previously reported results 23 . In bone marrow transplantation studies, overexpression of miR-146a in hematopoietic progenitors produced no detectable changes in megakaryocyte numbers, formation of platelets, or platelet function. Together, our findings extend the repertoire of miRNAs that potentially regulate platelet production, provide a useful dataset for future studies on this topic and show that miR146a, believed to inhibit platelet production indirectly by suppressing cytokine production 9 , has minimal autonomous effects when overexpressed in hematopoietic cells.
Materials and Methods

Tissue culture
Use of animals for this study was approved by the Animal Care and Use Committee at The
Children's Hospital of Philadelphia. 12.5-13.5 day pregnant mice (CD-1 strain) were obtained To assess morphology, cells were analyzed by cytocentrifugation and stained with May
Grunwald-Giemsa.
After 3 days of culture, megakaryocytes were further purified by a discontinuous bovine serum albumin (BSA) gradient (3%, 1.5% and 0%), and the bottom fraction, containing the largest cells, was used for RNA isolation 24 . RNA from mouse Ter119 -cells and megakaryocytes was isolated using Trizol reagent (Invitrogen, Carlsbad, CA). The quality of RNA was confirmed by molecular weight analysis using an Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA).
MicroRNA Array and statistical analysis
Microarray analysis was performed at the University of Pennsylvania Microarray Core Facility using Exiqon miRCURY LNA Arrays v10.0. Total RNA was assayed by Nanodrop spectrophotometry and Agilent Bioanalyzer RNA Pico and Small RNA LabChips; the samples ranged from 1.82 to 1.92 for A260/280 and from 8.9 to 9.9 for Bioanalyzer RIN indicating high RNA purity and integrity. Each total RNA sample (0.5 μg per reaction) was labeled with Hy3
and Hy5 dyes using the Exiqon Power Labeling Kit and automated microarray hybridizations was from EMFRET, Wuerzburg, Germany.
Megakaryocyte colony assays
Bone marrow-derived MNCs were sorted by flow cytometry according to GFP and c-kit expression. Isolated c-kit + /GFP + and c-kit + /GFP -cells were plated at 1x10 4 cells/ml in collagen based semisolid medium (StemCell Technologies, Vancouver, Canada) with Tpo (50 ng/ml), IL-6 (10 ng/ml) and IL-3 (10 ng/ml). After 7-8 days, colonies were dehydrated, fixed and stained according to manufacturer's protocol. Colonies were scored by light microscopy.
Platelet function tests
Platelet activation studies were performed at 9 weeks after BMT. Mice were anesthetized with 16 µg/g body weight tribromoethanol (Sigma, St. Louis, MO), and 100 µL of whole blood was collected by retro-orbital bleeding with a heparinized capillary tube. Platelet-rich plasma was 
Macrophage activation studies
Macrophages were generated from bone marrow cells by culture in macrophage colony stimulating factor, as described 27 . After 7 For personal use only. on April 2, 2017. by guest www.bloodjournal.org From
Results
Generation of murine megakaryocytes. The protocol for generating megakaryocytes from murine fetal liver progenitors is shown in Figure 1 and described in Materials and Methods.
Embryonic day 12.5-13.5 fetal livers were depleted of Ter119 + committed erythroid precursors using immunomagnetic beads ( Figure 1A ). The Ter119 -fraction was cultured in defined serum free medium with thrombopoietin. After 3-4 days, most cells expressed the megakaryocyte antigen CD41 ( Figure 1B ) and acquired typical megakaryocyte morphology including large size, multilobed nuclei and granular cytoplasm ( Figure 1C ). Cells within the cultures exhibited increased DNA content reflecting megakaryocyte endoreduplication ( Figure 1D ) and expressed lineage-specific genes ( Figure 1E ). Expression of the erythroid transcription factor gene Klf1 decreased, while that of Fli1, encoding a megakaryocyte transcription factor, increased ( Figure   1F ). Together, these findings confirm that the cultures contained abundant megakaryocytes. For miRNA profiling, we purified the largest, most mature megakaryocytes using a BSA gradient ( Figure 1C ).
MicroRNA microarray analysis of murine megakaryopoiesis. We compared miRNA expression in Ter119 -fetal liver cells and BSA gradient-purified megakaryocytes generated after three days of culture. Biologic triplicate samples were analyzed using an Exiqon locked nucleic acid (LNA) chip (Version 10.0), which interrogates the expression of 435 mouse miRNAs. The microarray data are deposited at Gene Expression Omnibus, accession #GSE22480. We identified 94 mouse microRNAs with at least 2-fold altered expression during megakaryocyte maturation and p values less than 0.05; 13 were up regulated and 81 down regulated ( Figure 2A and Table 1 ).
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To validate the array results we performed real-time quantitative polymerase chain reaction (Q-PCR) analysis on selected miRNAs that were up-or down-regulated to the greatest extent and conserved among species ( Figure 2B and 2C). The Q-PCR results were consistent with the microarray findings for all miRNAs analyzed.
We were particularly interested in miRNAs unique to megakaryocyte development and noticed in Q-PCR studies that miR-146a was induced about 20-fold in megakaryocytes but not in
Ter119
+ erythroblasts that derive from a common bipotential megakaryocyte-erythroid precursor (MEP) ( Figure 2 ). Of note, a previous study indicated that miR-146a is downregulated during human megakaryopoiesis and that overexpression of this miRNA inhibited megakaryocytic development of human CD34 + cells 23 . Since these prior results differ from the current findings,
we investigated further the expression of miR-146a by Q-PCR. Compared to lineage-depleted murine fetal liver cells, miR-146a was upregulated in cultured murine megakaryocytes, but not in Ter119 + erythroblasts ( Figure 2D ). MiR-146a was also upregulated during human megakaryocyte differentiation from purified CD34 + cells ( Figure 2D ). In murine fetal liver megakaryocytic differentiation cultures, miR-146a begins to increase at day 2, which coincides with the onset of megakaryocyte differentiation ( Figure 2E ). In Q-PCR analysis of purified platelet RNA, we noted early amplification of miR-146a signal with CT values ~20-21, but we were unable to normalize levels to U6 ribosomal RNA, which we found to be virtually absent.
This finding is consistent with the observation that miR-146a is present at relatively high level in purified platelets 22 . Together, these results indicate that our microarray data accurately reflect miRNA expression and that miR-146a is upregulated during mouse and human megakaryopoiesis.
Overexpression of miR-146a during in vitro megakaryopoiesis. We next investigated whether enforced expression of miR-146a influences murine megakaryocyte differentiation or maturation in culture ( Figure 3 ). We infected fetal liver Ter119 -cells with retrovirus encoding miR-146 or empty vector. The vector also encodes genes for puromycin resistance and green fluorescent protein (GFP). The infection rate was ~7-8% for miR-146a virus and ~30% for control virus.
Megakaryocytes were generated under puromycin selection. At culture day 4, both control and miR-146a-transduced cells similarly expressed megakaryocytic cell surface markers CD41 and CD42 ( Figure 3A ). Megakaryocytes overexpressing miR-146a by about 100-fold (Figure 3B) exhibited normal morphology ( Figure 3C ) and expression of megakaryocyte marker mRNAs ( Figure 3D ). For personal use only. on April 2, 2017. by guest www.bloodjournal.org From By 4 weeks, donor hematopoietic reconstitution, as measured by CD45.2 expression, was ~90%.
Overexpression of miR-
MiR-146a was overexpressed approximately ~65 fold in circulating MNCs ( Figure 4B ). There were no differences in peripheral blood erythrocyte, white blood cell or platelet levels in miR146a overexpressing mice compared to controls ( Table 2 ). The proportion of GFP + platelets compared to total platelet count, representing contribution from transduced progenitors, was similar in mice transplanted with miR-146a and control virus-transduced hematopoietic progenitors ( Figure 4C ). Also, for both groups of mice, the fraction of GFP + cells was similar for circulating GR1 + granulocytes, CD3 + T cells and B220 + B cells ( Figure 3D and not shown).
These data indicate that overexpression of miR-146a does not cause expansion, accumulation or diminution of any circulating blood lineages analyzed.
We sacrificed mice at 16 weeks post transplant to assess the effects of miR-146a overexpression on megakaryopoiesis. MiR-146a overexpressing megakaryocytes (GFP + /CD42 + ) were present at normal numbers in the bone marrow relative to megakaryocytes transduced with control miRNA 
MiR-146a overexpression impairs innate immune response.
Given that miR-146a overexpression produced no discernable effects on megakaryocyte or platelet development in vitro or in vivo, we sought to confirm that the virus used Figure 5D ). These results confirm prior studies on miR-146a actions and verify that the retrovirus used to overexpress this miRNA is functional and biologically active.
MiR-146a expression produces no detectable effects on platelet activation. To investigate whether miR-146a overexpression alters platelet function in vivo, we performed platelet activation studies on mice at 9 weeks after BMT ( Figure 6A ). We used three different agonists that activate platelets through distinct receptors and signaling pathways: ADP, convulxin, and AYP-PAR4 peptide. Platelets were treated with agonist and activation was measured by quantifying binding to fluorescent-labeled fibrinogen. Use of a flow cytometry based assay Figure 6B ).
Discussion
Prior studies have identified numerous miRNAs that augment or inhibit human megakaryocyte development either positively or negatively, although the full complement of miRNAs that regulate this process is not defined. It should be possible to gain new insights into the evolution and function of miRNAs during megakaryopoiesis through interspecies comparisons. To our knowledge, this is the first study to describe global miRNA expression during mouse megakaryocyte differentiation. In an experiment of similar design to ours, Garzon et al described miRNA expression during the differentiation of human CD34 + cells into megakaryocytes 15 . Of 18 miRNAs reported to be downregulated in that study, 13 (72%) were also downregulated in the current study ( 15, 17 . In general agreement, we found that the number of repressed miRNAs greatly exceeds the number of induced ones (13 vs. 81, Figure   2A and Numerous miRNAs induced during megakaryocytic differentiation were also upregulated during erythropoiesis ( Figure 2C ). It is possible that these miRNAs facilitate cellular processes that are . In this capacity, miR-146a negatively regulates megakaryopoiesis indirectly by suppressing the production of positively acting cytokines, including IL-6. Through this mechanism, it is believed that haploinsufficiency of miR-146a contributes to the megakaryocyte expansion and thrombocytosis commonly observed in 5q-myelodysplastic syndrome 9 . We found that pan-hematopoietic overexpression of miR-146a in vivo inhibited TLR signaling, consistent with prior studies. However, there were no detectable changes in megakaryocytes, circulating platelet counts or platelet activation properties by several agonists.
Our results sharply contrast with a previous report that miR-146a is suppressed during human megakaryopoiesis and that overexpression of this miRNA inhibits megakaryocyte proliferation and maturation during in vitro culture of CD34 + cells 23 . This might be partially explained by interspecies differences in miR-146a actions since our studies were performed exclusively in a murine system. It is also possible that miR-146a overexpression in hematopoietic tissues exerts different effects in vivo compared to in vitro. In any case, our observation that miR-146a-overexpressing bone marrow cells generate normal numbers of normal sized megakaryocyte
For personal use only. on April 2, 2017. by guest www.bloodjournal.org From colonies argues strongly against a cell-autonomous effect. Moreover, we found that miR-146a is upregulated during both mouse and human megakaryocyte differentiation. Further studies are required to better define the role of miR-146a in megakaryocyte development and to resolve the discrepancies between our current study and that of Labbaye et al 23 .
From our own findings, we derive several conclusions. First, overexpression of miR-146a in lympho-myeloid cells does not inhibit megakaryopoiesis indirectly by suppressing innate immunity, in contrast to the megakaryocyte enhancing effects of miR-146a haploinsufficiency.
Thus, endogenous levels of this miRNA are sufficient to suppress megakaryocyte-stimulating cytokine production, at least under baseline conditions. It is possible that overexpressed miR146a could suppress megakaryocytosis caused by inflammatory stress. Second, overexpressed miR-146a has minimal cell-autonomous effects on megakaryocyte differentiation, proliferation or platelet function. This conclusion is supported by analysis of genetically manipulated megakaryocytes and platelets in resident tissues and by in vitro colony assays of megakaryocyte precursors. However, our data do not entirely preclude a cell-intrinsic role for miR-146a in megakaryopoiesis. For example, endogenous levels of miR-146a may be sufficient to achieve biological effects that are not enhanced by retroviral overexpression. This possibility can be investigated further by loss of function studies. It is also possible that miR-146a influences megakaryocyte/platelet development in ways that are not detected by the assays employed here. This is consistent with the current concept that many miRNAs exert subtle effects, often elicited by specific tissue stresses [32] [33] [34] . 
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